C. Mark Schneyer

Affiliations

  • Evp, Chief Financial Officer at Acadia Pharmaceuticals Inc (ACAD), 2025-05-20
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ACAD $25.00 2,000 $50,000.00 62,130 2025-05-16 Filing
ACAD $14.60 3,498 $51,070.80 62,773 2025-05-02 Filing
ACAD $14.82 2,708 $40,132.56 59,456 2025-04-08 Filing
ACAD $17.05 3,171 $54,065.55 56,889 2025-03-26 Filing
ACAD $19.96 773 $15,429.08 53,882 2025-02-24 Filing